phase 3_initiation
saveStanford University — zanubrutinib (Phase III Trial Initiation)
community read0 votes
Therapy area: Immunology. Indication: Immunoglobulin G4-Related Disease (IgG4-RD)
Data sources
globaldata
Found something off?
same company · ±60 days · 6
- grantSTANFORD UNIVERSITY — An Artificial Intelligence Foundation Model for Functional Neuroimaging: Pers...Apr 15, 2026
- grantSTANFORD UNIVERSITY — T cell Contributions to Neointima Formation in Pulmonary HypertensionApr 15, 2026
- grantSTANFORD UNIVERSITY — Restoring Key Functions to the Industrialized Gut MicrobiomeApr 13, 2026
- grantSTANFORD UNIVERSITY — Faster MRI through portable Resonance Gradient Coils with seamless calibratio...Apr 10, 2026
- grantSTANFORD UNIVERSITY — Development of 3D Multi-cellular Cardiac Tissues for Modeling Delayed Radiati...Apr 10, 2026
- grantSTANFORD UNIVERSITY — Advancing iPSC-derived Thymic Epithelial Cells as Cell Therapy for T Cell Imm...Apr 8, 2026
related news · 3
- biopharma diveBiotech leaders campaign for Pazdur; Takeda to lay off 4,500 workers
- oncliveRetrospective Data Show Potential Real-World TTNT and OS Improvements With Next-Generation BTK Inhibitors in R/R MCL
- statNew U.S. recommendation on hepatitis B vaccine will have dire consequences, studies project
comments(0)
5-min edit window · permanent after that